Chu 2015.

Study characteristics
Methods	Study design: RCT, parallel groups Number of centres: 1 Country: USA
Participants	Randomised: 4 (median age 34 years, 2 females) Inclusion criteria: Patients with untreated patchy alopecia areata Exclusion criteria: Not stated
Interventions	Intervention 1: Intralesional triamcinolone 2.5 mg/mL (1.5 mg), once every 6 weeks for 36 weeks Intervention 2: Intralesional triamcinolone 5 mg/mL (3 mg), once every 6 weeks for 36 weeks Intervention 3: Intralesional triamcinolone 10 mg/mL (6 mg), once every 6 weeks for 36 weeks
Outcomes	Assessement at 36 weeks: Hair regrowth Hair density Hair caliber increase Side effects
Funding source	Not stated
Declarations of interest	No conflicts
Notes